Immunoscore Signature Predicts Postoperative Survival and Adjuvant Chemotherapeutic Benefits in Esophageal Squamous Cell Carcinoma

OBJECTIVE: The aim of this study was to construct the immunoscore (IS) to facilitate the prediction of postoperative survival and benefit from adjuvant chemotherapy (ACT) in esophageal squamous cell carcinoma (ESCC). METHODS: A total of 249 patients who received radical esophagectomy at Fudan Univer...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuge, Lingdun, Huang, Binhao, Xie, Juntao, Gao, Zhendong, Zheng, Difan, Zheng, Shanbo, Xiang, Jiaqing, Zhang, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751312/
https://www.ncbi.nlm.nih.gov/pubmed/33364836
http://dx.doi.org/10.2147/CMAR.S279684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751312/
https://www.ncbi.nlm.nih.gov/pubmed/33364836
http://dx.doi.org/10.2147/CMAR.S279684

Ejemplares similares